SLC23A1
geneOn this page
Also known as YSPL3SVCT1
Summary
SLC23A1 (solute carrier family 23 member 1, HGNC:10974) is a protein-coding gene on chromosome 5q31.2, encoding Solute carrier family 23 member 1 (Q9UHI7). Sodium:ascorbate cotransporter.
The absorption of vitamin C into the body and its distribution to organs requires two sodium-dependent vitamin C transporters. This gene encodes one of the two transporters. The encoded protein is active in bulk vitamin C transport involving epithelial surfaces. Previously, this gene had an official symbol of SLC23A2. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 9963 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 88 total
- Druggable target: yes
- MANE Select transcript:
NM_005847
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10974 |
| Approved symbol | SLC23A1 |
| Name | solute carrier family 23 member 1 |
| Location | 5q31.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | YSPL3, SVCT1 |
| Ensembl gene | ENSG00000170482 |
| Ensembl biotype | protein_coding |
| OMIM | 603790 |
| Entrez | 9963 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 7 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000348729, ENST00000353963, ENST00000502863, ENST00000503919, ENST00000504513, ENST00000506512, ENST00000508270, ENST00000882127, ENST00000882128, ENST00000882129
RefSeq mRNA: 2 — MANE Select: NM_005847
NM_005847, NM_152685
CCDS: CCDS4212, CCDS4213
Canonical transcript exons
ENST00000348729 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001128394 | 139380208 | 139380389 |
| ENSE00001385108 | 139380565 | 139380632 |
| ENSE00001812424 | 139367196 | 139367631 |
| ENSE00001942742 | 139383218 | 139383297 |
| ENSE00002224824 | 139379678 | 139379834 |
| ENSE00002294049 | 139379207 | 139379354 |
| ENSE00002455523 | 139377402 | 139377497 |
| ENSE00002476116 | 139371987 | 139372253 |
| ENSE00002481803 | 139377975 | 139378118 |
| ENSE00002492742 | 139378579 | 139378684 |
| ENSE00002504988 | 139378222 | 139378351 |
| ENSE00003495908 | 139380798 | 139380886 |
| ENSE00003572999 | 139381892 | 139382049 |
| ENSE00003634444 | 139379956 | 139380076 |
| ENSE00003643695 | 139382492 | 139382605 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 98.90.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1613 / max 52.9132, expressed in 43 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 63738 | 0.4576 | 68 |
| 63737 | 0.0708 | 26 |
| 63740 | 0.0555 | 23 |
| 63739 | 0.0349 | 21 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 98.90 | gold quality |
| right uterine tube | UBERON:0001302 | 98.68 | gold quality |
| kidney epithelium | UBERON:0004819 | 98.20 | gold quality |
| jejunal mucosa | UBERON:0000399 | 93.50 | gold quality |
| right lobe of liver | UBERON:0001114 | 89.49 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.79 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.78 | gold quality |
| duodenum | UBERON:0002114 | 86.82 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 85.70 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.43 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 85.33 | gold quality |
| small intestine | UBERON:0002108 | 84.43 | gold quality |
| liver | UBERON:0002107 | 84.28 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.89 | silver quality |
| fallopian tube | UBERON:0003889 | 82.91 | gold quality |
| kidney | UBERON:0002113 | 81.46 | gold quality |
| bronchial epithelial cell | CL:0002328 | 81.21 | gold quality |
| bronchus | UBERON:0002185 | 79.69 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.56 | gold quality |
| cortex of kidney | UBERON:0001225 | 77.65 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.88 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.90 | gold quality |
| adult organism | UBERON:0007023 | 71.86 | gold quality |
| gall bladder | UBERON:0002110 | 70.07 | gold quality |
| transverse colon | UBERON:0001157 | 69.95 | gold quality |
| jejunum | UBERON:0002115 | 69.78 | gold quality |
| bone marrow cell | CL:0002092 | 69.77 | silver quality |
| prostate gland | UBERON:0002367 | 69.45 | gold quality |
| sural nerve | UBERON:0015488 | 68.20 | gold quality |
| intestine | UBERON:0000160 | 67.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.57 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
30 targeting SLC23A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-3616-5P | 99.55 | 67.02 | 989 |
| HSA-MIR-573 | 99.55 | 67.44 | 955 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-516B-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-7162-5P | 99.46 | 68.08 | 1368 |
| HSA-MIR-150-3P | 99.43 | 70.51 | 920 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-491-3P | 98.88 | 68.86 | 1224 |
| HSA-MIR-4635 | 98.74 | 67.63 | 1339 |
| HSA-MIR-676-5P | 98.49 | 68.87 | 1492 |
| HSA-MIR-934 | 98.49 | 70.44 | 581 |
| HSA-MIR-6847-5P | 97.93 | 66.74 | 1808 |
| HSA-MIR-22-5P | 97.67 | 68.92 | 1355 |
| HSA-MIR-3200-5P | 97.34 | 65.97 | 826 |
| HSA-MIR-5192 | 96.89 | 63.35 | 879 |
| HSA-MIR-1178-5P | 95.83 | 64.12 | 504 |
| HSA-MIR-4474-5P | 94.23 | 67.95 | 568 |
| HSA-MIR-6789-5P | 94.05 | 66.19 | 285 |
Literature-anchored findings (GeneRIF, showing 38)
- SVCT1 is the transporter that allows vectorial uptake of ascorbic acid in differentiated CaCo-2 cells (PMID:12381735)
- Results provide the first direct resolution of functional hSVCT1 expression at the apical cell surface of polarized epithelia and define an apical targeting signal of relevance to transporters of diverse substrate specificity. (PMID:15084584)
- Functionally, SVCT1 expression led to more transport activity from the apical membrane, while SVCT2 expression only increased the uptake under the condition when basolateral membrane was exposed. (PMID:15993839)
- Findings link genetic variants in the vitamin C transporter gene SLC23A1 to spontaneous preterm birth. (PMID:16357110)
- C uptake is increased in UVB-irradiated keratinocytes through the translocation of SVCT-1 and regulates inflammatory response in the skin via the downregulation of IL-8 and MCP-1 production (PMID:17008880)
- SVCT1 is responsible for epidermal ascorbic acid supply, whereas SVCT2 mainly facilitates ascorbic acid transport in the dermal compartment (PMID:17664139)
- We present a transport model for SVCT1 that will provide a framework for investigating the impact of specific mutations and polymorphisms in SLC23A1 and help us better understand the contribution of SVCT1 to vitamin C metabolism in health and disease. (PMID:18094143)
- The results suggest that uncharged His51 of hSVCT1, directly or indirectly, contributes to substrate binding through the hydrogen bond. (PMID:18247577)
- SVCT1 may be targeted to facilitate the delivery of drugs with low bioavailability by conjugating with ascorbic acid (PMID:18417304)
- N-Glycosylation is therefore essential for SVCT1 functionality. (PMID:18619416)
- estrogen receptor 1, vitamin C receptors SLC23A1 and SLC23A2, and matrix metalloproteinase MMP3 and MMP9 are associated with susceptibility to lymphoma (PMID:18636124)
- The analysis of common single nucleotide polymorphisms in SLC23A1 revealed no association with colorectal adenoma risk. (PMID:18791929)
- Results using short interfering RNA suggest that in HepG2 cells, decreasing hSVCT2 message levels reduces the overall ascorbic acid uptake process more than decreasing hSVCT1 message levels. (PMID:18845575)
- These results collectively suggested a default apical targeting of SVCT, which is consistent with the evolution-based prediction. (PMID:19216494)
- common variants in SLC23A2, a gene that directly regulates active transport of ascorbic acid, can impact gastric cancer risk (PMID:19243932)
- Results describe the membrane topology of human SVCT1 and SVCT2, and the role of glycosylation on protein transport. (PMID:19379732)
- HNF-1alpha and/or HNF-1beta binding is required for SVCT1 expression (PMID:19741195)
- hSVCT1 and 2 promoters establish that ascorbic acid uptake by human liver epithelial cells is adaptively regulated and show that transcriptional mechanisms via HNF-1 in the hSVCT1 promoter may, in part, be involved in this regulation. (PMID:20471816)
- A genetic variant (rs33972313) in the SLC23A1 vitamin C active transporter locus was identified that is reliably associated with circulating concentrations of L-ascorbic acid in the general population. (PMID:20519558)
- In patients with hepatocellular cholestasis, primary biliary cirrhosis, haemochromatosis and non-alcoholic steatohepatitis, using real-time RT-PCR, an enhanced hepatic expression of both SLC23A1 and SLC23A2 was found. (PMID:21733302)
- glutathione depletion failed to affect ascorbic acid transport, and SVCT1 and SVCT2 expression in hepatoma cells. Therefore, our data indicate an essential role for glutathione in controlling vitamin C metabolism in rat hepatocytes and rat hepatoma cells (PMID:22348976)
- The SVCT1 was induced and localized to the apical membrane of tubular epithelial cells. (PMID:22990596)
- These findings show a role for Rab8a in the physiological function of SVCT1 in intestinal epithelia. (PMID:23014846)
- SVCT1 directly interacts with GRHPR. (PMID:23599041)
- Data show that the mRNA level of svct2 was approximately 600- to 900-fold higher than that of svct1 indicating SVCT2 is a main isoform in fibroblast OUMS-36 cells, and no significant difference in svct2 mRNA and protein between young and old cells. (PMID:23613229)
- Data suggest that N-terminal and C-terminal sorting signals interact, directly or indirectly, within each gene family (here, SVCT1 and SVCT2) in basolateral targeting of transmembrane proteins to basolateral cell membrane. (PMID:23837633)
- A genetic variant in the SLC23A1 ascorbate transporter locus was identified and is associated with an increased risk of Crohn disease in a white Canadian inflammatory bowel diseases cohort. (PMID:24284447)
- SNP rs6596473 of SLC23A1 is suggested to be associated with AgP. results add to previous reports vitamin C plays a role in pathogenesis of periodontitis. (PMID:24708273)
- polymorphisms in SLC23A1/2 genes influenced ascorbate concentration in aqueous humor and lens nucleus. (PMID:24815519)
- Data from observational/genetic association studies in Europe suggest an SNP in SLC23A1 (rs33972313) is associated with up-regulation of circulating L-ascorbic acid but not with any cardiometabolic/cardiovascular outcome investigated. [META-ANALYSIS] (PMID:25527764)
- consensus site for HNF1 that is crucial for the regulation of the human SVCT1 promoter is present in the SVCT1 rat promoter but has no effect on its transcriptional activity (PMID:25933589)
- Our findings show, for the first time, that transporters of the water-soluble vitamin ascorbic acid (i.e., the vitamin C transporters SVCT-1 and SVCT-2) are differentially expressed along the length of the intestinal tract and that the pattern of expression is mediated, at least in part, by transcriptional and epigenetic mechanism(s) affecting both Slc23a1 and Slc23a2 genes. (PMID:27932501)
- Posttranscriptional regulation of SVCT1 by miRNA in intestinal epithelial cells.Mir-103a target SVCT1 3’-UTR and regulates SVCT1 expression. (PMID:30616065)
- Limited Association Between Ascorbate Concentrations and Vitamin C Transporters in Renal Cell Carcinoma Cells and Clinical Samples. (PMID:34599650)
- Effects of functional variants of vitamin C transporter genes on apolipoprotein E E4-associated risk of cognitive decline: The Nakajima study. (PMID:34780525)
- Impact of SLC23A1 and SLC23A2 Polymorphisms on the Risk for Preeclampsia in a Chinese Han Population. (PMID:36310070)
- Vitamin C transporter SVCT1 serves a physiological role as a urate importer: functional analyses and in vivo investigations. (PMID:36749388)
- Dimeric transport mechanism of human vitamin C transporter SVCT1. (PMID:38956111)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc23a1 | ENSDARG00000015033 |
| mus_musculus | Slc23a1 | ENSMUSG00000024354 |
| rattus_norvegicus | Slc23a1 | ENSRNOG00000061695 |
| drosophila_melanogaster | CG6293 | FBGN0037807 |
Paralogs (2): SLC23A2 (ENSG00000089057), SLC23A3 (ENSG00000213901)
Protein
Protein identifiers
Solute carrier family 23 member 1 — Q9UHI7 (reviewed: Q9UHI7)
Alternative names: Na(+)/L-ascorbic acid transporter 1, Sodium-dependent vitamin C transporter 1, Yolk sac permease-like molecule 3
All UniProt accessions (3): Q9UHI7, H0Y902, H0YAJ1
UniProt curated annotations — full annotation on UniProt →
Function. Sodium:ascorbate cotransporter. Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate. Has retained some ancestral activity toward nucleobases such as urate, an oxidized purine. Low-affinity high-capacity sodium:urate cotransporter, may regulate serum urate levels by serving as a renal urate re-absorber. Inactive transporter.
Subcellular location. Cell membrane.
Tissue specificity. Highly expressed in adult small intestine, kidney, thymus, ovary, colon, prostate and liver, and in fetal kidney, liver and thymus.
Post-translational modifications. Phosphorylated.
Miscellaneous. Treatment with the protein kinase C stimulator PMA results in a 10-fold decrease in ascorbate accumulation in transfected cells.
Similarity. Belongs to the nucleobase:cation symporter-2 (NCS2) (TC 2.A.40) family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UHI7-1 | 1 | yes |
| Q9UHI7-2 | 2 | |
| Q9UHI7-3 | 3 |
RefSeq proteins (2): NP_005838, NP_689898 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006043 | NCS2 | Family |
Pfam: PF00860
Catalyzed reactions (Rhea), 2 shown:
- L-ascorbate(out) + 2 Na(+)(out) = L-ascorbate(in) + 2 Na(+)(in) (RHEA:69883)
- urate(out) + 2 Na(+)(out) = urate(in) + 2 Na(+)(in) (RHEA:76339)
UniProt features (96 total): helix 27, sequence conflict 15, topological domain 14, transmembrane region 12, turn 7, sequence variant 4, strand 4, modified residue 3, region of interest 2, compositionally biased region 2, glycosylation site 2, splice variant 2, chain 1, intramembrane region 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8JEW | ELECTRON MICROSCOPY | 2.49 |
| 8JEZ | ELECTRON MICROSCOPY | 2.6 |
| 8JF1 | ELECTRON MICROSCOPY | 2.85 |
| 8JF0 | ELECTRON MICROSCOPY | 3.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UHI7-F1 | 81.74 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 591, 593, 596
Glycosylation sites (2): 138, 144
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-196836 | Vitamin C (ascorbate) metabolism |
| R-HSA-1430728 | Metabolism |
| R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors |
| R-HSA-196854 | Metabolism of vitamins and cofactors |
MSigDB gene sets: 338 (showing top):
GSE45365_NK_CELL_VS_BCELL_UP, GOBP_RESPONSE_TO_ETHANOL, GOBP_CARBOHYDRATE_TRANSPORT, GOBP_REGULATION_OF_CELL_MORPHOGENESIS, GOBP_NEURON_PROJECTION_EXTENSION, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_GROWTH, THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN, GOBP_NEUROGENESIS, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND
GO Biological Process (12): sodium ion transport (GO:0006814), brain development (GO:0007420), response to toxic substance (GO:0009636), nucleobase transport (GO:0015851), L-ascorbic acid transmembrane transport (GO:0015882), L-ascorbic acid metabolic process (GO:0019852), lung development (GO:0030324), dehydroascorbic acid transport (GO:0070837), monoatomic ion transport (GO:0006811), urate transport (GO:0015747), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085)
GO Molecular Function (9): L-ascorbate:sodium symporter activity (GO:0008520), sodium ion transmembrane transporter activity (GO:0015081), urate transmembrane transporter activity (GO:0015143), nucleobase transmembrane transporter activity (GO:0015205), L-ascorbic acid transmembrane transporter activity (GO:0015229), dehydroascorbic acid transmembrane transporter activity (GO:0033300), protein binding (GO:0005515), symporter activity (GO:0015293), transmembrane transporter activity (GO:0022857)
GO Cellular Component (7): cytoplasm (GO:0005737), plasma membrane (GO:0005886), basal plasma membrane (GO:0009925), apical plasma membrane (GO:0016324), intracellular organelle (GO:0043229), extracellular exosome (GO:0070062), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Metabolism of water-soluble vitamins and cofactors | 1 |
| Metabolism of vitamins and cofactors | 1 |
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| animal organ development | 2 |
| nitrogen compound transport | 2 |
| transport | 2 |
| monosaccharide transmembrane transporter activity | 2 |
| carboxylic acid transmembrane transporter activity | 2 |
| vitamin transmembrane transporter activity | 2 |
| intracellular anatomical structure | 2 |
| cellular anatomical structure | 2 |
| plasma membrane region | 2 |
| metal ion transport | 1 |
| central nervous system development | 1 |
| head development | 1 |
| response to chemical | 1 |
| monosaccharide transmembrane transport | 1 |
| vitamin transmembrane transport | 1 |
| carboxylic acid transmembrane transport | 1 |
| monosaccharide metabolic process | 1 |
| carboxylic acid metabolic process | 1 |
| lactone metabolic process | 1 |
| respiratory tube development | 1 |
| respiratory system development | 1 |
| vitamin transport | 1 |
| sodium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| cellular process | 1 |
| organic acid:sodium symporter activity | 1 |
| carbohydrate:monoatomic cation symporter activity | 1 |
| sodium ion transmembrane transport | 1 |
| metal ion transmembrane transporter activity | 1 |
| urate transport | 1 |
| salt transmembrane transporter activity | 1 |
| nucleobase transport | 1 |
| transmembrane transporter activity | 1 |
| L-ascorbic acid transmembrane transport | 1 |
| dehydroascorbic acid transport | 1 |
| binding | 1 |
| secondary active transmembrane transporter activity | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| membrane | 1 |
Protein interactions and networks
STRING
1450 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC23A1 | MATR3 | P43243 | 841 |
| SLC23A1 | SFTPB | P07988 | 662 |
| SLC23A1 | SLC2A3 | P11169 | 584 |
| SLC23A1 | SLC2A1 | P11166 | 537 |
| SLC23A1 | SLC52A1 | Q9NWF4 | 460 |
| SLC23A1 | SLC44A4 | Q53GD3 | 458 |
| SLC23A1 | SLC5A6 | Q9Y289 | 454 |
| SLC23A1 | SLC6A20 | Q9NP91 | 447 |
| SLC23A1 | SIL1 | Q9H173 | 446 |
| SLC23A1 | SLC2A8 | Q9NY64 | 433 |
| SLC23A1 | SLC5A8 | Q8N695 | 431 |
| SLC23A1 | SLC2A12 | Q8TD20 | 429 |
| SLC23A1 | GATA1 | P15976 | 427 |
| SLC23A1 | SLC7A6 | Q92536 | 426 |
| SLC23A1 | SLC2A2 | P11168 | 419 |
IntAct
153 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-8 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SLC23A1 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.670 |
| GRHPR | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.630 |
| GRHPR | SLC23A1 | psi-mi:“MI:0403”(colocalization) | 0.630 |
| AHCYL1 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC23A1 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC23A1 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT31 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC23A1 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAMTSL4 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC23A1 | NOTCH2NLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-2 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SLC23A1 | AHCYL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | SLC23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (57): SLC23A1 (Two-hybrid), AHCYL1 (Two-hybrid), MTUS2 (Two-hybrid), ADAMTSL4 (Two-hybrid), KRTAP4-2 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), KRTAP10-8 (Two-hybrid), SLC23A1 (Two-hybrid), SLC23A1 (Two-hybrid)
ESM2 similar proteins: A2AJN7, A2AWR3, E9Q3M5, O13134, O22881, O88343, P02730, P23562, Q28677, Q2UVJ5, Q2Y0W8, Q32LP4, Q3E954, Q3TWI9, Q4U116, Q53P98, Q5DTL9, Q5R9A7, Q5RK27, Q63632, Q63633, Q657W3, Q6RI88, Q6RVG2, Q6U841, Q6Z0E2, Q7YRU6, Q7Z3F1, Q80ZA5, Q8JZR6, Q8NBS3, Q8VYR7, Q91V14, Q924N4, Q9GL77, Q9H2X9, Q9JI66, Q9JIS8, Q9M1P7, Q9SSG5
Diamond homologs: B0JZG0, O04472, P93039, Q0WPE9, Q27GI3, Q3E7D0, Q41760, Q60850, Q6PIS1, Q6SZ87, Q8GZD4, Q8RWE9, Q8VZQ5, Q94C70, Q9EPR4, Q9SHZ3, Q9UGH3, Q9UHI7, Q9WTW7, Q9WTW8, Q9Z2J0, Q3E956, A0A2A5K1W4, O32139, P0AGM7, P0AGM8, P39766, P41006, P45117, P75892, Q9CPL9, P50487, P42086
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 88 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 46.0× | 5e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 43.9× | 5e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 43.9× | 5e-06 |
| Assembly and cell surface presentation of NMDA receptors | 10 | 40.9× | 5e-12 |
| Dopamine Neurotransmitter Release Cycle | 5 | 40.0× | 7e-06 |
| Long-term potentiation | 5 | 38.4× | 7e-06 |
| Neurexins and neuroligins | 11 | 34.9× | 3e-12 |
| Protein-protein interactions at synapses | 7 | 30.0× | 3e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 9 | 64.6× | 4e-12 |
| protein localization to synapse | 6 | 56.7× | 1e-07 |
| receptor clustering | 7 | 53.9× | 1e-08 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 6 | 36.7× | 1e-06 |
| cell-cell adhesion | 9 | 11.3× | 7e-06 |
| protein-containing complex assembly | 8 | 11.2× | 3e-05 |
| chemical synaptic transmission | 7 | 6.7× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
88 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 6 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
3876 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:139379277:A:G | S335P | 1.000 |
| 5:139372238:C:G | R522P | 0.999 |
| 5:139378100:C:T | G443E | 0.999 |
| 5:139378101:C:A | G443W | 0.999 |
| 5:139378101:C:G | G443R | 0.999 |
| 5:139378101:C:T | G443R | 0.999 |
| 5:139378603:G:C | N385K | 0.999 |
| 5:139378603:G:T | N385K | 0.999 |
| 5:139378609:A:C | S383R | 0.999 |
| 5:139378609:A:T | S383R | 0.999 |
| 5:139378611:T:G | S383R | 0.999 |
| 5:139378668:C:A | G364C | 0.999 |
| 5:139378668:C:G | G364R | 0.999 |
| 5:139378682:C:T | G359D | 0.999 |
| 5:139378683:C:G | G359R | 0.999 |
| 5:139379252:G:T | A343D | 0.999 |
| 5:139379270:C:T | G337E | 0.999 |
| 5:139379276:G:A | S335F | 0.999 |
| 5:139379302:G:C | S326R | 0.999 |
| 5:139379302:G:T | S326R | 0.999 |
| 5:139379304:T:G | S326R | 0.999 |
| 5:139380274:A:G | L194P | 0.999 |
| 5:139372236:C:G | G523R | 0.998 |
| 5:139377416:T:A | D512V | 0.998 |
| 5:139377417:C:G | D512H | 0.998 |
| 5:139378043:C:T | G462E | 0.998 |
| 5:139378044:C:G | G462R | 0.998 |
| 5:139378044:C:T | G462R | 0.998 |
| 5:139378057:G:C | N457K | 0.998 |
| 5:139378057:G:T | N457K | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000142384 (5:139375987 A>C), RS1000685694 (5:139370543 G>A), RS1000888807 (5:139387494 T>C), RS1001092691 (5:139382109 G>A), RS1001285683 (5:139369985 A>G), RS1001472147 (5:139375478 C>G), RS1001667426 (5:139383445 A>C), RS1001833857 (5:139382151 C>A,T), RS1001861383 (5:139370188 G>A), RS1001949224 (5:139382355 C>A,T), RS1002221997 (5:139381836 G>A,C), RS1002297125 (5:139381570 G>A), RS1002649825 (5:139373985 T>C), RS1003047112 (5:139385035 G>A), RS1003143591 (5:139368096 G>A)
Disease associations
OMIM: gene MIM:603790 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5209632 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC23 family of ascorbic acid transporters
Most potent curated ligand interactions (1 total), top 1:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| phloretin | Inhibition | 4.19 | pKi |
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Ascorbic Acid | increases expression, decreases expression, decreases reaction, increases transport, affects abundance (+1 more) | 4 |
| Cyclosporine | decreases expression | 4 |
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| Aflatoxin B1 | affects methylation, decreases expression, affects expression | 3 |
| bisphenol A | increases abundance, decreases expression, increases expression, decreases reaction | 2 |
| Quercetin | decreases reaction, increases transport, decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression, increases methylation | 2 |
| ginger extract | increases expression, decreases reaction, increases abundance | 1 |
| methyleugenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| pirinixic acid | increases expression, affects binding, increases activity | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| benzo(e)pyrene | affects methylation | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 6-deoxy-6-bromoascorbic acid | affects transport | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Aldehydes | decreases expression | 1 |
| Bilirubin | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Methapyrilene | affects methylation | 1 |
| Oils, Volatile | decreases reaction, increases abundance, increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Taurocholic Acid | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5209615 | Functional | Substrate uptake and inhibition of the Na(+)/L-Ascorbic Acid Transporter 1 (SVCT1, SLC23A1) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC23A1 cells (PubChem AID: 1794810) | Membrane potential based assay for SLC23A1 using HEK-293 SLC23A1 OE cells |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4SG | HuH7-SLC23A1-KO-c2 | Cancer cell line | Male |
| CVCL_D4SH | HuH7-SLC23A1-KO-c3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Ascorbic Acid